BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 16061590)

  • 1. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P
    Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma.
    Bukstein DA; Luskin AT; Bernstein A
    Ann Allergy Asthma Immunol; 2003 May; 90(5):543-9. PubMed ID: 12775136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
    BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB; Rosario N; Aristizabal G; Loeys T; Noonan G; Gaile S; Smugar SS; Polos PG
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):511-7. PubMed ID: 20568384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
    Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
    Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
    Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
    J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
    O'Sullivan S; Akveld M; Burke CM; Poulter LW
    Am J Respir Crit Care Med; 2003 Mar; 167(5):745-50. PubMed ID: 12480610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
    ; Peters SP; Anthonisen N; Castro M; Holbrook JT; Irvin CG; Smith LJ; Wise RA
    N Engl J Med; 2007 May; 356(20):2027-39. PubMed ID: 17507702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
    Zeiger RS; Szefler SJ; Phillips BR; Schatz M; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM;
    J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.